My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    1.

    Early pathological features of the cornea in toxic epidermal necrolysis.

    Williams GP, Mudhar HS, Leyland M.

    Br J Ophthalmol. 2007 Sep;91(9):1129-32. Epub 2007 Mar 14.PMID: 17360733 [PubMed - indexed for MEDLINE]Related articles

    2.

    Long-term complications of toxic epidermal necrolysis (Lyell's disease). Clinical and histopathologic study.

    de Felice GP, Caroli R, Autelitano A.

    Ophthalmologica. 1987;195(1):1-6.PMID: 3658330 [PubMed - indexed for MEDLINE]Related articles

    3.

    Evaluation of the potential role of cytokines in toxic epidermal necrolysis.

    Nassif A, Moslehi H, Le Gouvello S, Bagot M, Lyonnet L, Michel L, Boumsell L, Bensussan A, Roujeau JC.

    J Invest Dermatol. 2004 Nov;123(5):850-5.PMID: 15482470 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.

    Nassif A, Bensussan A, Dorothée G, Mami-Chouaib F, Bachot N, Bagot M, Boumsell L, Roujeau JC.

    J Invest Dermatol. 2002 Apr;118(4):728-33.PMID: 11918724 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases.

    Villada G, Roujeau JC, Clérici T, Bourgault I, Revuz J.

    Arch Dermatol. 1992 Jan;128(1):50-3.PMID: 1739287 [PubMed - indexed for MEDLINE]Related articles

    6.

    Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.

    Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, Bagot M, Roujeau JC.

    J Allergy Clin Immunol. 2004 Nov;114(5):1209-15.PMID: 15536433 [PubMed - indexed for MEDLINE]Related articles

    7.

    In vivo biopsy by laser confocal microscopy for evaluation of traumatic recurrent corneal erosion.

    Chikama T, Takahashi N, Wakuta M, Morishige N, Nishida T.

    Mol Vis. 2008;14:2333-9. Epub 2008 Dec 15.PMID: 19093010 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.

    Friedmann PS, Strickland I, Pirmohamed M, Park BK.

    Arch Dermatol. 1994 May;130(5):598-604.PMID: 8179341 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Epidermal necrolysis: mechanisms of keratinocyte apoptosis]

    Roujeau JC, Gélard K, Bensussan A.

    Med Sci (Paris). 2006 Feb;22(2):188-91. Review. French. PMID: 16457761 [PubMed - indexed for MEDLINE]Related articles

    10.

    Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement.

    Kobayashi A, Yoshita T, Sugiyama K, Miyashita K, Niida Y, Koizumi S, Tseng SC.

    Ophthalmology. 2006 Jan;113(1):126-32. Epub 2005 Dec 1.PMID: 16324747 [PubMed - indexed for MEDLINE]Related articles

    11.

    T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells.

    Miyauchi H, Hosokawa H, Akaeda T, Iba H, Asada Y.

    Arch Dermatol. 1991 Jun;127(6):851-5.PMID: 2036032 [PubMed - indexed for MEDLINE]Related articles

    12.

    Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.

    Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H.

    Am J Pathol. 2003 May;162(5):1515-20.PMID: 12707034 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Toxic epidermal necrolysis: revisiting the tentative link between early apoptosis and late necrosis (review).

    Paquet P, Pierard GE.

    Int J Mol Med. 2007 Jan;19(1):3-10. Review.PMID: 17143541 [PubMed - indexed for MEDLINE]Related articles

    14.

    Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis.

    Paquet P, Paquet F, Al Saleh W, Reper P, Vanderkelen A, Piérard GE.

    Am J Dermatopathol. 2000 Oct;22(5):413-7.PMID: 11048976 [PubMed - indexed for MEDLINE]Related articles

    15.

    Penetrating keratoplasty in cicatrizing conjunctival diseases.

    Tugal-Tutkun I, Akova YA, Foster CS.

    Ophthalmology. 1995 Apr;102(4):576-85.PMID: 7724175 [PubMed - indexed for MEDLINE]Related articles

    16.

    Impaired antigen presentation in toxic epidermal necrolysis.

    Bagot M, Charue D, Heslan M, Wechsler J, Roujeau JC, Revuz J.

    Arch Dermatol. 1993 Jun;129(6):721-7.PMID: 8507074 [PubMed - indexed for MEDLINE]Related articles

    17.

    Photo-induced toxic epidermal necrolysis caused by clobazam.

    Redondo P, Vicente J, España A, Subira ML, De Felipe I, Quintanilla E.

    Br J Dermatol. 1996 Dec;135(6):999-1002.PMID: 8977728 [PubMed - indexed for MEDLINE]Related articles

    18.

    Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors.

    Le Cleach L, Delaire S, Boumsell L, Bagot M, Bourgault-Villada I, Bensussan A, Roujeau JC.

    Clin Exp Immunol. 2000 Jan;119(1):225-30.PMID: 10606987 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.

    Khalili B, Bahna SL.

    Ann Allergy Asthma Immunol. 2006 Sep;97(3):272-80; quiz 281-3, 320. Review.PMID: 17042130 [PubMed - indexed for MEDLINE]Related articles

    20.

    Area and depth of surfactant-induced corneal injury predicts extent of subsequent ocular responses.

    Jester JV, Petroll WM, Bean J, Parker RD, Carr GJ, Cavanagh HD, Maurer JK.

    Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2610-25.PMID: 9856771 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity